Matinas BioPharma Inc.
MTNB | AMEX
$1.51
-$0.39 (-20.53%)
At close: Oct 30, 2026, 3:59 PM ET
$1.19
-$0.32 (-21.19%)
Pre-market:
Nov 2, 2026, 6:02 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -0.29 | -0.10 | -2.05 | -8.33 | -10.02 | -13 |
PEG Ratio | 0 | 0.02 | -0.03 | 0.21 | 2.76 | 4.99 |
PS Ratio | n/a | n/a | 42.86 | 34 | 6.43K | 1.69K |
PB Ratio | 0.66 | 0.33 | 2.44 | 2.96 | 4.04 | 4.20 |
P/FCF Ratio | -0.46 | -0.16 | -3.03 | -5.41 | -13.71 | -15.41 |
P/OCF Ratio | -0.46 | -0.16 | -3.07 | -5.66 | -13.94 | -15.42 |
OCF/S Ratio | n/a | n/a | -1.39K | -600.88 | -46.13K | -10.97K |
Debt / Equity Ratio | 0.28 | 0.38 | 0.18 | 0.11 | 0.09 | 0.06 |
Quick Ratio | 2.79 | 3.01 | 5.93 | 8.06 | 11.73 | 17.25 |
Current Ratio | 2.79 | 3.01 | 5.93 | 8.06 | 11.73 | 17.25 |
Asset Turnover | n/a | n/a | 0.04 | 0.04 | 0 | 0 |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -214.18% | -319.51% | -119.20% | -57.31% | -44.35% | -35.22% |
Return on Assets | -143.52% | -191.84% | -91.39% | -26.62% | -37.97% | -31.63% |
Return on Invested Capital | -108.06% | -187.09% | -102.69% | -32.72% | -42.99% | -35.69% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | 254.99% |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | -3.04K% |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | -3.11K% |
Gross Profit Margin | n/a | n/a | 14.14% | -423.15% | -44.09K% | -8.97K% |
Net Profit Margin | n/a | n/a | -2.09K% | -658.63% | -70.55K% | -14.18K% |
Pretax Profit Margin | n/a | n/a | -2.09K% | -658.63% | -70.55K% | -14.18K% |
Operating Profit Margin | n/a | n/a | -2.17K% | -771.33% | -74.95K% | -15.29K% |
FCF Margin | n/a | n/a | -1.41K% | -628.86% | -46.92K% | -10.97K% |
EBITDA Margin | n/a | n/a | -2.01K% | -647.46% | -69.71K% | -15.11K% |
Add to Watchlist
Select watchlists to add or remove MTNB